CRH Medical Corp (TSE:CRH) – Investment analysts at Beacon Securities reduced their FY2017 earnings per share (EPS) estimates for CRH Medical Corp in a research note issued on Monday. Beacon Securities analyst D. Cooper now anticipates that the company will post earnings of $0.45 per share for the year, down from their prior forecast of $0.46. Beacon Securities also issued estimates for CRH Medical Corp’s FY2018 earnings at $0.40 EPS.

CRH has been the topic of a number of other reports. Royal Bank Of Canada lowered their target price on CRH Medical Corp from C$11.00 to C$10.00 and set a “sector perform” rating on the stock in a report on Friday, April 28th. TD Securities reaffirmed a “buy” rating and set a C$12.00 target price on shares of CRH Medical Corp in a report on Friday, April 28th. National Bank Financial lowered their target price on CRH Medical Corp from C$9.00 to C$7.00 in a report on Monday. Bloom Burton lowered CRH Medical Corp from a “buy” rating to an “accumulate” rating in a report on Friday, July 14th. Finally, Scotiabank lowered CRH Medical Corp from an “outperform” rating to a “sector perform” rating and lowered their target price for the stock from C$10.00 to C$8.00 in a report on Friday, July 14th. Five research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. CRH Medical Corp presently has an average rating of “Hold” and a consensus target price of C$8.75.

COPYRIGHT VIOLATION NOTICE: This piece was first published by American Banking News and is owned by of American Banking News. If you are accessing this piece on another website, it was stolen and reposted in violation of international copyright & trademark legislation. The correct version of this piece can be read at https://www.americanbankingnews.com/2017/07/19/beacon-securities-analysts-reduce-earnings-estimates-for-crh-medical-corp-crh.html.

CRH Medical Corp (CRH) traded up 1.44% during midday trading on Wednesday, hitting $4.24. 312,870 shares of the company traded hands. CRH Medical Corp has a 12-month low of $4.05 and a 12-month high of $12.35. The stock has a market cap of $313.42 million and a P/E ratio of 34.75. The stock has a 50 day moving average of $7.21 and a 200 day moving average of $8.72.

In related news, Director David Johnson sold 30,000 shares of the stock in a transaction on Wednesday, June 28th. The stock was sold at an average price of C$5.67, for a total value of C$170,100.00.

CRH Medical Corp Company Profile

CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.

Receive News & Ratings for CRH Medical Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Corp and related companies with MarketBeat.com's FREE daily email newsletter.